HAI Pathogens and Antimicrobial Resistance Report, 2018-2021

Adult Data Tables

Print
PAGE 17 of 19

‹View Table of Contents

Related Pages

Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1 for Surgical Categories with High Pathogen Volume,2 Adults, 2018-2021

Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1 for Surgical Categories with High Pathogen Volume, Adults, 2018-2021
Abdominal Orthopedic Ob/Gyn Cardiac
  Pathogen, Antimicrobial Phenotype # Reported % Tested %R # Reported % Tested %R # Reported % Tested %R # Reported % Tested %R
Urgent Threats Acinetobacter spp. 185 376 89 46
Carbapenem-NS 81.1 39.3 78.5 26.4 70.8 3.2 80.4 48.6
Select Enterobacterales3 33,687 7,888 5,648 1,803
Carbapenem-resistant (CRE) 74.9 1.9 72.3 1.2 71.8 0.5 76.1 1.2
Serious Threats Select Enterobacterales4 28,755 4,760 4,696 1,185
Extended-spectrum cephalosporin-NS 84.3 18.4 83.9 18.8 83.2 14.8 85.2 19.7
Enterobacter spp. 4,433 2,922 824 523
Cefepime-NS 77.9 11.0 75.8 5.1 75.4 2.1 78.8 5.8
Enterococcus faecalis 10,722 2,851 2,485 322
Vancomycin-resistant (VRE) 89.2 2.3 88.5 3.4 88.5 0.7 89.1 3.8
Enterococcus faecium 5,273 519 165 90
Vancomycin-resistant (VRE) 91.8 45.9 92.1 75.5 90.9 32.7 94.4 77.6
Pseudomonas aeruginosa 6,541 3,702 1,079 913
Multidrug-resistant (MDR) 94.8 5.0 93.6 2.8 93.4 1.0 96.5 4.0
Staphylococcus aureus 6,407 18,744 3,025 2,574
Meth/ox/cefox – resistant (MRSA) 91.4 52.6 90.2 36.4 91.6 38.7 91.2 33.5

Note: Refer to Technical Resources for more information about phenotype definitions, acronyms, and terms used in this table.

Footnotes:

  1. As classified by CDC’s 2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance
  2. The top 4 surgical categories by pathogen volume are shown in this table. Refer to CDC’s Antibiotic Resistance & Patient Safety Portal for antimicrobial resistance data for each NHSN procedure code.
  3. Consists of E. coli, Klebsiella oxytoca, Klebsiella pneumoniae, Klebsiella aerogenes, and Enterobacter spp.
  4. Consists of E. coli, Klebsiella oxytoca, and Klebsiella pneumoniae.

HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Adult HAIs

  1. HAI Pathogens and Antimicrobial Resistance Report 2018-2021 Data Tables - Adult HAIs
  2. Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
  3. Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
  4. Table 3. The Top 15 HAI Pathogens Reported to NHSN
  5. Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
  6. Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type
  7. Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type
  8. Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type
  9. Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type
  10. Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
  11. Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume
  12. Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type
  13. Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  14. Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status
  15. Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  16. Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type
  17. ›Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume
  18. Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume
  19. Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI Type